EVOTEC SEINH O.N.
6.51
EUR
(-0.31%)
04/25/2025 - 11:59
Open 15 min delayed data - Germany Stocks
| Open: | 6.53 |
| Change: | -0.02 |
| Volume: | 16,824 |
| Low: | 6.40 |
| High: | 6.53 |
| High / Low range: | 0.13 |
| Type: | Stocks |
| Ticker: | EVT |
| ISIN: | DE0005664809 |
EVOTEC SEINH O.N. news, videos and press releases - Page 10
For more news please use our advanced search feature.
EVOTEC SEINH O.N. - More news...
EVOTEC SEINH O.N. - More news...
- 07/01/2021 - 05:30 DGAP-News: Evotec creates long-term growth opportunities by initiating 'Campus Levi-Montalcini' in Verona
- 06/15/2021 - 15:20 DGAP-News: Evotec SE virtual Annual General Meeting 2021 approves all proposed agenda items
- 06/15/2021 - 11:35 Evotec SE Virtual Annual General Meeting 2021; Approves All Proposed Agenda Items
- 06/15/2021 - 05:30 DGAP-News: Evotec launches 'PRROTECT', a pre-competitive initiative to be better prepared for future pandemics
- 06/15/2021 - 02:00 Evotec Launches 'PRROTECT', A Pre-Competitive Initiative to Be Better Prepared for Future Pandemics
- 05/11/2021 - 05:00 DGAP-News: EVOTEC SE REPORTS RESULTS FOR THE FIRST QUARTER 2021 AND PROVIDES CORPORATE UPDATE
- 05/11/2021 - 01:20 Evotec SE Reports Results for The First Quarter 2021 and Provides Corporate Update
- 05/06/2021 - 05:30 DGAP-News: Evotec launches 'beLAB1407' to accelerate translational research from the UK's academic life science ecosystem in collaboration with Bristol Myers Squibb
- 05/04/2021 - 09:30 DGAP-News: Evotec SE to announce results for the first quarter 2021 on 11 May 2021
- 05/04/2021 - 06:00 Evotec SE To Announce Results for The First Quarter 2021 On 11 May 2021
- 05/04/2021 - 05:30 DGAP-News: Evotec and the GCKD study enter into strategic collaboration to build a unique molecular patient database
- 05/04/2021 - 02:00 Evotec and the GCKD Study Enter into Strategic Collaboration to Build A Unique Molecular Patient Database
- 04/26/2021 - 05:30 DGAP-News: Bristol Myers Squibb exercises option to extend targeted protein degradation partnership with Evotec
- 04/26/2021 - 01:50 Bristol Myers Squibb Exercises Option to Extend Targeted Protein Degradation Partnership with Evotec
- 04/23/2021 - 11:03 DGAP-Adhoc: Chairman of the Supervisory Board of Evotec to resign from office effective as of the end of the Annual General Meeting on 15 June 2021
- 04/23/2021 - 07:20 Chairman of the Supervisory Board of Evotec to resign from office effective as of the end of the Annual General Meeting on 15 June 2021
- 04/20/2021 - 05:30 DGAP-News: Evotec accelerates access to biologic therapeutics with initiation of manufacturing facility in Toulouse
- 04/20/2021 - 01:50 Evotec Accelerates Access to Biologic Therapeutics with Initiation of Manufacturing Facility in Toulouse
- 04/19/2021 - 06:31 DGAP-News: Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801
- 04/19/2021 - 03:00 Evotec enters partnership with Kazia Therapeutics for clinical development of EVT801
- 04/13/2021 - 05:30 DGAP-News: Evotec launches 'beLAB2122', translating academic innovation from leading German life science region in collaboration with Bristol Myers Squibb
- 04/13/2021 - 02:00 Evotec Launches 'BeLAB2122', Translating Academic Innovation from Leading German Life Science Region in Collaboration with Bristol Myers Squibb
- 04/09/2021 - 05:30 DGAP-News: Evotec and Exscientia announce start of human clinical trials of novel immuno-oncology drug
- 04/09/2021 - 02:00 Evotec And Exscientia Announce Start of Human Clinical Trials of Novel Immuno-Oncology Drug
- 03/25/2021 - 06:00 DGAP-News: EVOTEC SE FISCAL YEAR 2020 RESULTS: GAINING SPEED ON 'THE DATA-DRIVEN R&D AUTOBAHN TO CURES'
- 03/25/2021 - 02:30 Evotec SE Fiscal Year 2020 Results: Gaining Speed On 'The Data-Driven R&D Autobahn to Cures'
- 03/22/2021 - 06:30 DGAP-News: Evotec and Takeda enter strategic RNA targeting drug discovery and development alliance
- 03/22/2021 - 02:50 Evotec and Takeda Enter Strategic RNA Targeting Drug Discovery and Development Alliance
- 03/18/2021 - 10:45 DGAP-News: Evotec SE to announce results for fiscal year 2020 on 25 March 2021
- 03/18/2021 - 07:10 Evotec SE to announce results for fiscal year 2020 on 25 March 2021
